Teleflex Commences $500M Senior Notes Due 2032 Offering
Teleflex Says Interventional Urology Business Unit Releases New Clinical Data Across Two Major Urological Congresses, Reinforcing Value Of UroLift System And Barrigel Rectal Spacer In Improving Patient-Centered Outcomes
Truist Securities Reiterates Hold on Teleflex, Raises Price Target to $143
RBC Capital Upgrades Teleflex (TFX)
RBC Capital Upgrades Teleflex to Outperform, Raises Price Target to $155
Wells Fargo Maintains Equal-Weight on Teleflex, Raises Price Target to $138
Teleflex (NYSE:TFX) Beats Q1 Estimates and Guides In Line, Stock Surges Pre-Market
Teleflex Incorporated 2026 Q1 - Results - Earnings Call Presentation
Teleflex Incorporated (TFX) Q1 2026 Earnings Call Transcript
Teleflex Affirms FY2026 Adj EPS Guidance of $6.25-$6.55 vs $6.72 Est
Teleflex Affirms FY2026 GAAP EPS Guidance of $2.90-$3.20 vs $2.23 Est
Teleflex Q1 Adj. EPS $1.39 Beats $1.21 Estimate, Sales $548.300M Beat $533.339M Estimate
Teleflex shares are trading higher following a report suggesting that CVC Capital Partners and GTCR have teamed up and submitted a takeover offer for the company.
Teleflex Stock Surges Over 8% In Pre-Market Trading: Here's Why
'CVC, GTCR Weigh Take-Private Of Medical Equipment Provider Teleflex' - Bloomberg
Raymond James Upgrades Teleflex (TFX)
Raymond James Upgrades Teleflex to Outperform, Announces $128 Price Target
Activist Investor Urges Teleflex To Engage Potential Buyers
Teleflex Says Previously Announced Sale Transactions On Track To Close In H2 of 2026; Expects $1.8B of Net Proceeds For Buyback And Debt Paydown; Restructuring Plan Expected To Achieve $50M Annual Pre-Tax Cost Savings By Mid-2028
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.